Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
About us
Contact
Links
About us
Contact
Links
Accordion Title
Accordion Content
more items +
What stocks may need to rise in ‘a market for only the most bright-eyed optimists’
Does Palantir face a new threat from Salesforce? Software giants clash over lucrative government contracts.
The end of ‘de minimis’ has hit Temu and Shein. Now it’s a problem for bigger companies like FedEx.
StubHub’s stock starts trading Wednesday. The IPO is a bet on the polarizing practice of ticket resale.
Investors are in for a wild week — and the Fed meeting is just the beginning
Here’s where you can find higher yields on your cash now, as Fed cuts loom and CD rates are already falling
Wall Street hates REITs — why that might be good news for you
Trump is suing the New York Times for $15 billion. Here’s how it’s different from his ‘60 Minutes’ lawsuit.
Could your employer take away your 401(k) match? Sherwin-Williams just did it.
Bloom Energy’s stock is surging — and could ride Oracle’s growth to even more gains
Why the Fed’s rate cut might not boost the economy
GE Aerospace’s stock heads for first record high in 25 years. What’s behind this year’s big gains.
What stocks may need to rise in ‘a market for only the most bright-eyed optimists’
Does Palantir face a new threat from Salesforce? Software giants clash over lucrative government contracts.
The end of ‘de minimis’ has hit Temu and Shein. Now it’s a problem for bigger companies like FedEx.
StubHub’s stock starts trading Wednesday. The IPO is a bet on the polarizing practice of ticket resale.
Investors are in for a wild week — and the Fed meeting is just the beginning
Here’s where you can find higher yields on your cash now, as Fed cuts loom and CD rates are already falling
Wall Street hates REITs — why that might be good news for you
Trump is suing the New York Times for $15 billion. Here’s how it’s different from his ‘60 Minutes’ lawsuit.
Could your employer take away your 401(k) match? Sherwin-Williams just did it.
Bloom Energy’s stock is surging — and could ride Oracle’s growth to even more gains
Why the Fed’s rate cut might not boost the economy
GE Aerospace’s stock heads for first record high in 25 years. What’s behind this year’s big gains.
A pill that reverses Alzheimer’s disease? This medical breakthrough shows promise.
9-08-24
Research at UCLA shows restored brain function and memory.
Share this on:
